Female hormone replacement pills usually contain estrogen, progesterone, or a progestin. They can help with menopause symptoms such as hot flashes, night sweats, and vaginal dryness, but the right choice depends on your uterus status, age, time since menopause, symptoms, and health history. A clinician should guide treatment. 1 7
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →What are female hormone replacement pills?
Female hormone replacement pills are oral forms of menopausal hormone therapy. They may contain estrogen alone or estrogen combined with progesterone or a progestin. Oral hormone therapy is systemic, meaning it circulates through the bloodstream rather than working only in one area of the body. 1 9
How oral estrogen, progesterone, and progestins differ
Estrogen, including estradiol, replaces some of the estrogen that falls during the menopause transition. Progesterone is the hormone made naturally after ovulation; a progestin is a medication designed to act similarly in the body. Both progesterone and progestins can help protect the uterine lining when systemic estrogen is used. 1 9
Why uterus status matters when choosing estrogen-only vs combined therapy
For someone with a uterus, systemic estrogen by itself can cause endometrial hyperplasia, meaning overgrowth of the uterine lining, and can raise endometrial cancer risk. Adding progesterone or a progestin lowers that risk. People who have had a hysterectomy may be candidates for estrogen-only therapy, but that decision still depends on their individual history. 1 9
How pills compare with patches, creams, injections, and local vaginal therapy
Pills are not the only way to use hormone therapy. Patches deliver estrogen through the skin, while local vaginal estrogen is intended for vaginal and urinary symptoms and has less whole-body exposure than systemic therapy. Creams and injections may also be prescribed in specific settings. The route matters because absorption, convenience, side effects, and risk discussions can differ. 7 9
| Option | Where it works | May fit someone seeking | Important consideration |
|---|---|---|---|
| Oral estrogen with or without progesterone | Systemic, throughout the body | A pill-based systemic option for bothersome menopause symptoms | May not be appropriate with some clotting, stroke, liver, or cancer histories. 9 |
| Transdermal estrogen patch | Systemic, through the skin | A non-pill systemic route | A clinician should review skin tolerance, dose, and individual risks. 7 |
| Local vaginal estrogen | Mostly local vaginal and urinary tissues | Vaginal dryness, discomfort with sex, or urinary symptoms | It is not intended to address hot flashes or other systemic symptoms. 7 |
| Creams or injections | Depends on the formulation and prescription | People whose clinician identifies a reason for another route | Product quality, indication, and monitoring matter, especially for compounded products. 9 |
What symptoms can hormone replacement pills help with?
Hormone therapy has its strongest evidence for vasomotor symptoms—hot flashes and night sweats—and for some vaginal and urinary symptoms related to menopause. It may also help prevent menopause-related bone loss, but it is not automatically the right choice for every person with osteopenia or osteoporosis. 1 7
- Hot flashes and night sweats can disrupt sleep, work, and daily comfort. Estrogen is an established treatment for these symptoms. 1
- Vaginal dryness, burning, irritation, pain with sex, and some urinary symptoms can be part of genitourinary syndrome of menopause. Local or systemic therapy may be considered depending on the symptoms and medical history. 1 7
- Sleep can improve when night sweats improve, but hormone therapy should not be presented as a proven treatment for insomnia, depression, dementia, or cognitive decline by itself. The KEEPS Continuation Study did not support using menopausal hormone therapy for cognitive benefit. 4
- Estrogen can reduce menopause-related bone loss, but a clinician should consider fracture risk, other bone treatments, and the risks of systemic therapy. 1 8
What are signs a woman may need to ask about HRT?
A person may want to ask about hormone therapy when symptoms are affecting sleep, work, relationships, or quality of life. Moderate-to-severe vasomotor symptoms are a common reason to discuss it, but a conversation is not the same as a diagnosis or a prescription. 7
- Frequent hot flashes or night sweats that interfere with daily life or sleep. 1
- Persistent vaginal dryness, burning, pain with sex, or urinary symptoms that do not improve with nonprescription measures. 1
- Menopause before age 40, also called primary ovarian insufficiency in some cases, or menopause caused by surgery or medical treatment. These situations need individualized care. 7
- A need to review whether symptoms could be related to pregnancy, thyroid disease, anemia, medications, depression, sleep apnea, or another condition. 7
What is the best hormone replacement pill?
There is no single best hormone replacement pill for every woman. The key decision is often whether you have a uterus, followed by your symptoms, preferences, age, years since menopause, and medical risks. 7 9
Estrogen-only therapy may be considered after hysterectomy. Combined estrogen-plus-progestin therapy is generally used when a uterus is present because the progestin component protects the endometrium. In the Women’s Health Initiative, estrogen plus progestin was associated with increased breast cancer incidence compared with placebo, which is one reason clinicians individualize treatment rather than treating HRT as risk-free. 2
Research from the Kronos Early Estrogen Prevention Study, or KEEPS, also shows why broad claims about hormone therapy are not helpful: findings can vary by timing, formulation, route, and the population studied. Hormone therapy should not be used with a promise of heart or brain protection. 3 5 6
3-min quiz
Talk through your menopause symptoms online
Chia offers clinician-reviewed menopause care, including an HRT for Women protocol for eligible patients. A licensed US provider reviews your health questionnaire and prescribes only when clinically appropriate; a prescription is not guaranteed. Medications are compounded by US state-licensed 503A pharmacies and shipped to your door. Compounded drugs are not FDA-approved.
What happens if a female takes hormone pills?
Hormone pills change hormone signaling in the body. Benefits and side effects may appear over weeks to months, and the response is not the same for everyone. Estrogen may reduce vasomotor and vaginal symptoms, while progesterone or a progestin is used to protect the uterine lining for many people taking systemic estrogen. 1 7
Possible side effects include breast tenderness, headache, nausea, bloating, spotting or bleeding, and mood changes. Serious risks can include blood clots, stroke, heart attack, gallbladder disease, and certain cancers, depending on the formulation and a person’s history. New chest pain, shortness of breath, coughing blood, one-sided leg swelling, sudden severe headache, weakness, trouble speaking, or unexpected vaginal bleeding needs urgent medical attention. 9
What are the risks of oral hormone replacement therapy?
Oral hormone replacement therapy can be appropriate for some people, but it has meaningful risks that deserve an upfront discussion. Risk changes with age and time since menopause, as well as the hormone type, route, dose, and a person’s cancer, clotting, and cardiovascular history. 7 9
- Breast cancer: In a Women’s Health Initiative randomized trial, estrogen plus progestin increased breast cancer incidence compared with placebo. 2
- Blood clots and stroke: Systemic estrogen-containing products carry warnings about thromboembolic and cardiovascular events. A clinician should review clotting history, smoking, migraine history, blood pressure, and other risk factors. 9
- Uterine cancer: Unopposed systemic estrogen raises endometrial cancer risk in people with a uterus. 1 9
- Heart and brain claims: KEEPS research does not justify using menopausal hormone therapy as a proven strategy to prevent heart disease, dementia, or cognitive decline. 3 4 5
What age is too late for estrogen?
There is no universal cutoff age, but starting systemic hormone therapy later requires a more careful risk-benefit discussion. Starting after age 60 or more than 10 years after menopause is often approached differently than starting near menopause because baseline risks can be higher. 7
That does not mean someone over 60 can never discuss estrogen. It means the clinician should clarify the goal, review alternatives, and consider whether local treatment or a nonhormonal option better fits the symptom and risk profile. 7
How does female hormone therapy work at Chia?
At Chia, eligible patients can discuss menopause symptoms through a 100% online visit. Our HRT for Women protocol includes Estradiol Oral plus Progesterone IR and currently starts at $119 per month. A licensed US provider reviews the health questionnaire and prescribes only when clinically appropriate. 7
We also offer estradiol as a cream, injection, or transdermal patch, with plans currently starting at $109 per month for listed options. Progesterone is available as a cream or injection, with plans currently starting at $109 per month for listed options. Your provider—not an article—determines whether a hormone, route, or combination is appropriate.
| Chia option | Listed form | What the care process includes |
|---|---|---|
| HRT for Women | Estradiol Oral + Progesterone IR | Online questionnaire, licensed-provider review, and provider-guided care; plans currently start at $119/mo. |
| Estradiol | Cream, injection, transdermal patch | Provider review of symptoms, uterus status, and relevant risks; listed plans start at $109/mo. |
| Progesterone | Cream, injection | Provider review of whether progesterone is appropriate for the treatment plan; listed plans start at $109/mo. |
If prescribed, medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Providers guide dosing and adjustments over time, and patients can message their care team through the patient portal. For more on what an online evaluation involves, see our guide to getting HRT safely and our overview of hormone replacement therapy for women.
How should someone prepare for an HRT consultation?
A useful HRT visit starts with a clear symptom and health history. Bring a timeline of symptoms and menstrual changes if you have one, especially if you are in perimenopause or are unsure when menopause began. 7
- Write down hot flashes, night sweats, sleep changes, vaginal or urinary symptoms, bleeding changes, and how they affect daily life.
- Share whether you still have a uterus, have had a hysterectomy, or have had ovarian surgery.
- List current medications, supplements, smoking status, migraine history, blood pressure concerns, and any personal or family history of blood clots, stroke, heart disease, breast cancer, or uterine cancer. 9
- Ask why a pill, patch, local vaginal option, cream, or injection may or may not fit your goals and history.
- Review our guide to estrogen and progesterone side effects before your visit if you want a fuller list of questions to raise.
When should you get help now?
Seek urgent care for symptoms that may signal a clot, stroke, heart problem, or severe allergic reaction. Sudden one-sided weakness, trouble speaking, chest pain, shortness of breath, or a swollen painful leg should not wait for a routine hormone consultation. 9
Contact a clinician promptly for new unexplained vaginal bleeding after menopause, especially if you are using hormone therapy. Bleeding can have many causes and needs evaluation rather than self-adjusting a hormone dose. 9
No. Both may contain hormones, but they are used for different goals and use different formulations. Birth control is designed mainly to prevent pregnancy, while menopausal hormone therapy is used to address symptoms related to declining ovarian hormone production. 1
Weight changes are common around midlife and can be related to aging, sleep, activity, muscle mass, diet, and menopause itself. Hormone therapy should not be expected to cause weight loss or used as a weight-loss treatment. 7
No. Compounded medications are not FDA-approved. They should be prescribed only after an individualized clinical evaluation and dispensed through an appropriate licensed pharmacy.
Yes, online care can include a health questionnaire and licensed-provider review. A prescription is not guaranteed, and the clinician may recommend in-person care, testing, or another treatment based on your history.
There is no one-size-fits-all end date. A clinician should revisit the benefits, side effects, changing health risks, and treatment goals regularly, especially as age and time since menopause increase. 7
3-min quiz
Start with a clinician-reviewed HRT evaluation
If menopause symptoms are affecting your quality of life, you can start Chia’s online eligibility questionnaire. A licensed US provider reviews each case and prescribes only when clinically appropriate; a prescription is never guaranteed. Learn more about our HRT for Women protocol. Medications are compounded through state-licensed 503A pharmacies, shipped to your door, and are not FDA-approved.
References
- 1.National Library of Medicine. Estrogen and Progestin (Hormone Replacement Therapy). MedlinePlus, 2024.
- 2.Chlebowski RT, Kuller LH, Prentice RL, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. New England Journal of Medicine. 2009.
- 3.Miller VM, Taylor HS, Naftolin F, et al. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric. 2021.
- 4.Gleason CE, Dowling NM, Kara F, et al. Long-term cognitive effects of menopausal hormone therapy: Findings from the KEEPS Continuation Study. PLoS Medicine. 2024.
- 5.Kling JM, Lahr BA, Bailey KR, et al. Endothelial function in women of the Kronos Early Estrogen Prevention Study. Climacteric. 2015.
- 6.Zeydan B, Lowe VJ, Tosakulwong N, et al. Sleep quality and cortical amyloid-β deposition in postmenopausal women of the Kronos Early Estrogen Prevention Study. Neuroreport. 2021.
- 7.The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022.
- 8.US Preventive Services Task Force. Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions. JAMA. 2022.
- 9.National Library of Medicine. Estradiol Tablets: Prescribing Information. DailyMed. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
